HeartSciences Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
HSCS Nasdaq 3840 heartsciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for HeartSciences Inc.

HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm - Jun 5th, 2025 7:06 am
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - Jun 4th, 2025 7:00 am
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value - Jun 3rd, 2025 7:00 am
HeartSciences signs first MyoVista Insights platform customer - May 30th, 2025 7:05 am
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - May 29th, 2025 7:00 am
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 - May 20th, 2025 7:00 am
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream - May 20th, 2025 5:00 am
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson - May 8th, 2025 7:00 am
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - May 7th, 2025 7:00 am
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program - May 1st, 2025 7:00 am
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - Mar 13th, 2025 2:15 pm
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications - Mar 10th, 2025 7:00 am
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - Dec 16th, 2024 2:15 pm
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - Nov 13th, 2024 7:00 am
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 14th, 2024 2:15 pm
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - Sep 12th, 2024 2:15 pm
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - Sep 12th, 2024 7:00 am
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results - Jul 29th, 2024 2:05 pm
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - Jul 26th, 2024 7:00 am
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - Jul 25th, 2024 6:30 am